*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : RC1250000
CHEMICAL NAME : 20-Norcrotalanan-11,15-dione,
3,8-didehydro-14,19-dihydro-12,13-dihydroxy-,
(13-alpha,14- alpha)-
CAS REGISTRY NUMBER : 23291-96-5
LAST UPDATED : 199606
DATA ITEMS CITED : 4
MOLECULAR FORMULA : C16-H21-N-O6
MOLECULAR WEIGHT : 323.38
WISWESSER LINE NOTATION : T55-11- 1A P EN IOV NVO BU FUTJ K1 LQ L1 MQ M1
COMPOUND DESCRIPTOR : Tumorigen
SYNONYMS/TRADE NAMES :
* Dehydromonocrotaline
* Monocrotaline pyrrole
* Monocrotaline pyrrole metabolite
* Monocrotaline, 3,8-didehydro-
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 16 mg/kg
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - other changes
Liver - other changes
REFERENCE :
CBINA8 Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland
Ltd., POB 85, Limerick, Ireland) V.1- 1969- Volume(issue)/page/year:
12,299,1976
TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 5 mg/kg
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - other changes
REFERENCE :
JPTLAS Journal of Pathology. (John Wiley & Sons, Inc., 605 Third Ave., New
York, NY 10158) V.97- 1969- Volume(issue)/page/year: 100,169,1970
** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 3 mg/kg/5W-I
TOXIC EFFECTS :
Skin and Appendages - dermatitis, other (after systemic exposure)
REFERENCE :
JPTLAS Journal of Pathology. (John Wiley & Sons, Inc., 605 Third Ave., New
York, NY 10158) V.97- 1969- Volume(issue)/page/year: 118,121,1976
** TUMORIGENIC DATA **
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Administration onto the skin
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1504 mg/kg/47W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Skin and Appendages - tumors
Tumorigenic - tumors at site of application
REFERENCE :
CALEDQ Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland
Ltd., POB 85, Limerick, Ireland) V.1- 1975- Volume(issue)/page/year:
17,61,1982
*** END OF RECORD ***